Answers are grounded in this paper and cite their sources.
Psoriasis is a skin disease that is evidenced primarily by plaques which can be seen throughout the body. Genetic predisposition that combines with an environmental trigger of the immune system is believed to be the root cause of psoriasis. This leads to signaling factors which coordinate the progression of inflammation and psoriatic plaques. Psoriatic patients commonly use topical agents, phototherapy, and systemic agents; however, biological therapies have become increasingly popular. This is primarily due to recent advances in the study of psoriasis which have shown that monoclonal antibodies and dimeric fusion proteins inhibit key signaling molecules within the inflammatory cascade such as TNFa, IL-12 and IL-23. This article reviews the advances made to understand the role of TNFa in the progression of psoriasis, discusses treatment options such as topical agents, phototherapy and systemic agents, and then compares a variety of monoclonal antibodies and dimeric fusion proteins as biological therapies. penetrate the lymphatic system, activate T cells, and engender the secretion of cytokines which induce the inflammatory cascade and psoriatic skin plaques However, in the innate immune system there are more identifiable mediators. For instance, toll-like receptors (TLRs) which are type 1 membrane glycoproteins that recognize pathogen associated molecular patterns (PAMPs), are important in the inflammatory cascade Within this cascade the keratinocyte barrier can be disturbed, NK lymphocytes can be activated, and natural killer receptors can be expressed. Interferon gamma (IFN), released by NK lymphocytes, and TNF, released by keratinocytes, work together to create inflammation, which is a physical characteristic of plaque psoriasis Another prevalent characteristic of plaque psoriasis is epidermal hyperplasia. Within this condition, keratinocytes proliferate and within the focal regions Type 1 effectors accumulate and induce cytokines such as IFN, and TNF [16, Specifically, IL-12 and IL-23 are related to T cell differentiation and activation of T helper 1 cells phenotypes.
No takes yet. Share an insight, caveat, or question.
SS Raju (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: